CNSP CIK: 1729427

CNS Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.5
FY22:
−10.6
FY23:
−14.1
FY24:
−17.1
FY25:
−13.8
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
0.00
FY23:
0.00
FY24:
0.00
FY25:
−0.02
Change from FY21 to FY25
millions USD
FY21:
4.51
FY22:
15.6
FY23:
4.64
FY24:
23.0
FY25:
14.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.5
FY22:
−10.6
FY23:
−14.1
FY24:
−17.1
FY25:
−13.8

All amounts in millions USD Data source:SEC EDGAR